About David Matlin
David Matlin is a director at Clene.
Form D filings name David Matlin as a director at Accuryn Medical and Dermasensor.
David Matlin reports to the SEC as a director, officer or major shareholder of 13 public companies, including TriSalus Life Sciences (TLSI), U.s. Well Services Holdings (USWS) and Lonestar Resources US (LONE).
David Matlin first appears on SEC filings in 2007.
Experience
This experience comes from SEC filings. The years are when the filings name David Matlin in the role, so the role may have started earlier or lasted longer.
CI
Clene Inc.
Director
2021 – 2026 · Public company (CLNN)
Potrero Medical, Inc.
Director
2026 · Hayward, CA
Medical monitoring systems help clinicians track critically ill patients' kidney function.
TI
TriSalus Life Sciences, Inc.
Chief Financial Officer and director
2020 – 2026 · Public company (TLSI)
UL
U.s. Well Services Holdings, LLC
Chief Executive Officer and director
2017 – 2022 · Public company (USWS)
LI
Lonestar Resources US Inc.
10% owner
2020 – 2021 · Public company (LONE)
FI
Flagstar Bancorp Inc.
Director
2009 – 2021 · Public company
MI
MedAvail Holdings, Inc.
10% owner
2019 – 2020 · Public company (MDVL)
CI
CalAtlantic Group, Inc.
Director and 10% owner
2008 – 2017 · Public company (CAA)
GI
Gleacher & Company, Inc.
10% owner
2007 – 2014 · Public company (GLCH)
PI
Polymer Group Inc.
10% owner
2011 · Public company (POLGA.OB)
GI
Global Aviation Holdings Inc.
Director and 10% owner
2010 · Public company (GLAH)
HC
Huntsman CORP
Director and 10% owner
2007 – 2009 · Public company (HUN)
TC
Toreador Resources Corp.
10% owner
2008 – 2009 · Public company (TRGL)
TI
Thornburg Mortgage Inc.
Director and 10% owner
2008 – 2009 · Public company (TMA)
Key Colleagues at Startups
The people David Matlin works with at each company, as listed on that company's latest Form D.
Potrero Medical, Inc. · Form D, May 29, 2026
Mark Goldwasser
Director
RR
Ram Reddy
Director
Rich Keenan
Sr. Regional Vice President of Sales
Maurice Ferre
Director
TD
Todd Dunn
CEO
MS
Mike Stansky
Director
Khalid Ghafari
Chief Financial Officer
Christopher Dewey
Executive Chairman
CH
Clay Heighten
Director
Dermasensor, Inc. · Form D, Dec 5, 2024